NovaBay Pharmaceuticals, Inc. (AMEX:NBY) shares are trading higher after the company announced it reached a definitive ...

(NYSE American: NBY) ("NovaBay"). The Brand offers several products for ocular health including cleansi EMERYVILLE, Calif., September 20, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American ...

EMERYVILLE, Calif. - NovaBay Pharmaceuticals, Inc. (NYSE American: NBY)宣布以950万美元的现金交易将其Avenova品牌出售给PRN Physician Recommended Nutriceuticals, LLC。该交易预计将在2024年第四季度完成，但需满足惯例成交条件并获得NovaBay股东的批准。 NovaBay的首 ...

NovaBay Pharmaceuticals (NBY) has entered into a definitive asset purchase agreement with PRN Physician Recommended Nutriceuticals, ...

Work Metallic bipolar plates are crucial for the development of compact and lightweight proton exchange membrane fuel cell ...

Acumen Health Holdings, LLC, a professionally recommended, consumer-preferred dietary supplements company focused on eye ...

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering. NovaBay Pharmaceuticals shares are trading ...

Niobay Metals Inc. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company explores for niobium, tantalum, titanium, and phosphate properties.

Short interest in NovaBay Pharmaceuticals Inc (AMEX:NBY) decreased during the last reporting period, falling from 94.89K to 32.28K. This put 2.39% of the company's publicly available shares short.